DURHAM, NC--(Marketwire - October 09, 2007) - Serenex, Inc., a leader in the discovery and development of small molecule Heat Shock Protein 90 (Hsp90) inhibitors, announced today that Dr. Richard Kent, chief executive officer, is scheduled to present at the Biotechnology Industry Organization (BIO) Investor Forum taking place in San Francisco at The Palace Hotel.
